IBDEI21U ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34354,1,3,0)
 ;;=3^Huntington's Disease
 ;;^UTILITY(U,$J,358.3,34354,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,34354,2)
 ;;=^5003751
 ;;^UTILITY(U,$J,358.3,34355,0)
 ;;=G11.3^^157^1746^9
 ;;^UTILITY(U,$J,358.3,34355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34355,1,3,0)
 ;;=3^Cerebellar Ataxia w/ Defective DNA Repair
 ;;^UTILITY(U,$J,358.3,34355,1,4,0)
 ;;=4^G11.3
 ;;^UTILITY(U,$J,358.3,34355,2)
 ;;=^5003755
 ;;^UTILITY(U,$J,358.3,34356,0)
 ;;=G11.8^^157^1746^22
 ;;^UTILITY(U,$J,358.3,34356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34356,1,3,0)
 ;;=3^Hereditary Ataxias,Other
 ;;^UTILITY(U,$J,358.3,34356,1,4,0)
 ;;=4^G11.8
 ;;^UTILITY(U,$J,358.3,34356,2)
 ;;=^5003757
 ;;^UTILITY(U,$J,358.3,34357,0)
 ;;=G12.9^^157^1746^36
 ;;^UTILITY(U,$J,358.3,34357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34357,1,3,0)
 ;;=3^Spinal Muscular Atrophy,Unspec
 ;;^UTILITY(U,$J,358.3,34357,1,4,0)
 ;;=4^G12.9
 ;;^UTILITY(U,$J,358.3,34357,2)
 ;;=^5003764
 ;;^UTILITY(U,$J,358.3,34358,0)
 ;;=G12.21^^157^1746^6
 ;;^UTILITY(U,$J,358.3,34358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34358,1,3,0)
 ;;=3^Amyotrophic Lateral Sclerosis
 ;;^UTILITY(U,$J,358.3,34358,1,4,0)
 ;;=4^G12.21
 ;;^UTILITY(U,$J,358.3,34358,2)
 ;;=^6639
 ;;^UTILITY(U,$J,358.3,34359,0)
 ;;=A81.9^^157^1746^8
 ;;^UTILITY(U,$J,358.3,34359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34359,1,3,0)
 ;;=3^Atypical Virus Infection of CNS,Unspec
 ;;^UTILITY(U,$J,358.3,34359,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,34359,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,34360,0)
 ;;=A81.09^^157^1746^11
 ;;^UTILITY(U,$J,358.3,34360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34360,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease NEC
 ;;^UTILITY(U,$J,358.3,34360,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,34360,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,34361,0)
 ;;=A81.00^^157^1746^12
 ;;^UTILITY(U,$J,358.3,34361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34361,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,34361,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,34361,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,34362,0)
 ;;=A81.01^^157^1746^13
 ;;^UTILITY(U,$J,358.3,34362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34362,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,34362,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,34362,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,34363,0)
 ;;=A81.89^^157^1746^7
 ;;^UTILITY(U,$J,358.3,34363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34363,1,3,0)
 ;;=3^Atypical Virus Infection of CNS NEC
 ;;^UTILITY(U,$J,358.3,34363,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,34363,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,34364,0)
 ;;=A81.2^^157^1746^33
 ;;^UTILITY(U,$J,358.3,34364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34364,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,34364,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,34364,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,34365,0)
 ;;=B20.^^157^1746^20
 ;;^UTILITY(U,$J,358.3,34365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34365,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,34365,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,34365,2)
 ;;=^5000555^F02.81
 ;;^UTILITY(U,$J,358.3,34366,0)
 ;;=B20.^^157^1746^21
 ;;^UTILITY(U,$J,358.3,34366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34366,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,34366,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,34366,2)
 ;;=^5000555^F02.80
 ;;^UTILITY(U,$J,358.3,34367,0)
 ;;=F10.27^^157^1746^1
